Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion type Assertion NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_head.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion description "[Clinical data show that mixed COX-1/COX-2 inhibitors such as aspirin, but not COX-2 selective inhibitors such as rofecoxib, induce bronchoconstriction and asthma in sensitive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_provenance.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion evidence source_evidence_literature NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_provenance.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion SIO_000772 18753249 NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_provenance.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion wasDerivedFrom befree-20140225 NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_provenance.
- NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_assertion wasGeneratedBy ECO_0000203 NP250253.RAPFchfyAWnHy_tN0gc3JUHKQyRnpxEKA9pqQboo7rJ2A130_provenance.